MUC16 and non-small cell lung carcinoma: The statistically significant increase in the expression of MUC16 in PDAC (n = 171, P = 3.6e–12) and NSCLC (n = 347, P = 4e–21) patients was observed as compared to benign pancreas (n = 179) and lung control samples (n = 483) (Supplementary Fig. 1a).